Overview

A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users

Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
Dimebon will not exhibit abuse potential when compared to placebo or a positive control (alprazolam).
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Collaborator:
Medivation, Inc.
Treatments:
Alprazolam